Schedule 13G ownership disclosure

Ampio Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 03209T109

Event date: 2018-08-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,500,000
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-052561
Form type
SC 13G
Filer
Ampio Pharmaceuticals, Inc.
CIK
CIK 1411906
Filed
Aug 17, 2018
Reporting period
Aug 09, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub